Breo vs. Ventolin

See how Breo and Ventolin compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Breo is a once-daily maintenance inhaler that controls asthma and COPD over time, while Ventolin is a rescue inhaler used for sudden breathing problems.

  • Breo combines a steroid and long-acting bronchodilator and cannot treat an active asthma attack, which is exactly what Ventolin is designed to do.

  • Because they serve different purposes, many patients use both: Breo every day for control and Ventolin as needed for flare-ups.

Breo vs. Ventolin Drug Summary

Breo

Breo is a combination inhaled corticosteroid and long-acting beta-agonist (ICS/LABA) taken once daily to control asthma and COPD over time. It is delivered through a dry-powder Ellipta inhaler and is not meant for sudden symptoms. Breo is FDA-approved for asthma in patients 5 and older and for COPD maintenance.

Ventolin

Ventolin is a short-acting beta-agonist (SABA) bronchodilator used to relieve sudden asthma or COPD symptoms as they happen. It is inhaled through a metered-dose HFA inhaler and taken as needed rather than on a fixed schedule. Ventolin is FDA-approved for bronchospasm relief and for preventing exercise-induced symptoms in patients 4 and older.

Breo vs. Ventolin Side Effects

Breo

Most common
Nasopharyngitis (up to 9%)
Headache (up to 6%)
Oral candidiasis (up to 5%)
Back pain (up to 3%)

Ventolin

Most common
Throat irritation (up to 10%)
Viral respiratory infections (up to 7%)
Upper respiratory inflammation (up to 5%)
Cough (up to 5%)

Breo vs. Ventolin Dosage

Breo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50 mcg/25 mcg once daily At the start
Maximum dose 50 mcg/25 mcg once daily Same as starting
Dose changes None Fixed dose

Ventolin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2 inhalations pre-exercise At the start
Maximum dose 2 inhalations pre-exercise Same as starting
Dose changes None Fixed dose

Breo vs. Ventolin Indications

Breo

Breo is approved as a daily maintenance treatment for asthma in patients 5 and older and for COPD, including chronic bronchitis and emphysema. It works by reducing airway inflammation and keeping airways open over 24 hours. It is not a substitute for a rescue inhaler during an attack.

  • Maintenance treatment of asthma (ages 5+)

  • Maintenance treatment of COPD, including chronic bronchitis and emphysema

  • Available in three dose strengths for different needs

  • Not approved for acute bronchospasm or exacerbations

Ventolin

Ventolin is approved to treat or prevent bronchospasm in patients 4 and older with reversible airway disease. It is also used shortly before exercise to prevent exercise-induced bronchospasm. It works within minutes to open airways during an asthma or COPD flare.

  • Treatment of acute bronchospasm (ages 4+)

  • Prevention of exercise-induced bronchospasm

  • Used as needed, not on a fixed daily schedule

  • Not approved for children under 4

Breo vs. Ventolin Pros and Cons

Breo

Breo treats the underlying inflammation behind asthma and COPD with one inhalation a day, which can simplify long-term management. Because it contains a LABA, it carries a boxed warning and must be paired with a steroid, which is already built into the combination. It costs more than a rescue inhaler like Ventolin, though a GSK savings program can lower the price for eligible patients.

Pros

  • Once-daily dosing simplifies long-term control

  • Treats underlying airway inflammation, not just symptoms

  • Approved for both asthma and COPD

  • As low as $0 to $35 per month for eligible patients under GSK's copay cap program

Cons

  • Boxed warning for increased asthma-related death risk with LABA use

  • Not for acute symptoms; cannot replace a rescue inhaler

  • Contraindicated in patients with severe milk protein allergy

  • Roughly $225 to $550 per month without insurance, before savings programs

Ventolin

Ventolin acts within minutes to relieve sudden bronchospasm, making it the standard rescue option for asthma and COPD flares. It does not address airway inflammation, so it is not meant for daily long-term control. It is inexpensive and widely available, especially as a generic.

Pros

  • Works within minutes to relieve acute symptoms

  • Roughly $28 to $45 per month without insurance, far less than Breo's list price

  • Can be used as needed rather than on a schedule

  • Effective for preventing exercise-induced bronchospasm

Cons

  • Does not treat underlying airway inflammation

  • Overuse can raise risk of serious cardiovascular effects

  • Frequent use often signals poor asthma or COPD control

  • Not intended for regular, everyday symptom management

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.